Furthermore, Eomes+ Th cells are increased in the peripheral blood and cerebrospinal fluid (CSF) of SPMS patients where the level of these cells was associated with actively progressing disease and so acted as a biomarker to predict SPMS patients at risk of developing worsening disease [24]. This evidence concerns the gene EOMES and secondary progressive multiple sclerosis.